我国科研人员开发可用于癌症免疫治疗的“纳米标记机器人”；支付宝推出国内首个AI付

Group 1 - Chinese researchers have developed a "nano-marking robot" for cancer immunotherapy, utilizing proximity labeling technology to create engineered nanoenzymes that can accurately identify cancer cells, showing promising results in mouse tumor models and clinical samples [1] - The research aims to pave the way for smarter and more efficient next-generation immunotherapies by addressing the challenge of cancer cells disguising themselves and providing insufficient natural signals for immune cells to attack [1] Group 2 - Yushutech's founder Wang Xingxing highlighted the current challenges in the robotics industry, particularly the difficulties in data collection and utilization, which hinder the effective deployment of AI models in robotics [2] - The robotics sector is facing a dual bottleneck of insufficient quality data and low utilization rates, alongside AI models that struggle with precise control, particularly in applications like dexterous hands [2] - Wang emphasized the need for the industry to focus on technological fundamentals, advocating for continued efforts in data accumulation and algorithm breakthroughs to bridge the gap between demonstration and practical application [2]